Nutriband Inc. (NTRB) vs Telomir Pharmaceuticals, Inc. Common Stock (TELO)

A side-by-side comparison of Nutriband Inc. and Telomir Pharmaceuticals, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

NTRB

Nutriband Inc.

$81M

$6.70HealthcareDelayed quote: Oct 6, 2026, 3:39 PM EDT

TELO

Telomir Pharmaceuticals, Inc. Common Stock

$83M

$1.21HealthcareDelayed quote: Oct 6, 2026, 3:39 PM EDT

Total return — NTRB vs TELO

growth of $100 · dividends reinvested · last 3y

NTRB +192.9% (+43.1%/yr)TELO -82.7% (-44.3%/yr)NTRB compounded faster over this window

Log scale — wide-divergence pair

NTRB TELO

NTRB vs TELO: by the numbers

•TELO is the larger company ($83M vs $81M market cap).
•Both run net losses; TELO's is the smaller (0.00% vs -430.43% net margin).

Metrics side by side

Valuation

Metric	NTRB	TELO
Forward P/E	4.26	N/A
P/S ratio	50.31	N/A
P/B ratio	15.28	16.53

Profitability

Metric	NTRB	TELO
Gross margin	33.14%	0.00%
Operating margin	-408.41%	0.00%
Net margin	-430.43%	0.00%
ROE	-130.67%	-116.74%
ROIC	-126.99%	-120.93%

Growth (annualized)

Metric	NTRB	TELO
Revenue CAGR (5Y)	3.12%	N/A
Total return CAGR (5Y)	6.67%	N/A

Go deeper

Full NTRB analysis Full TELO analysis Interactive comparison tool

Dig into the metrics

Nutrib ROE Telomir Pharmaceuticals, Inc. Common Stock ROE Nutrib operating margin Telomir Pharmaceuticals, Inc. Common Stock operating margin Nutrib revenue growth Telomir Pharmaceuticals, Inc. Common Stock revenue growth Nutrib free cash flow Telomir Pharmaceuticals, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.